Science Explorer Interactive view Map
Nonprofit · Camperdown · Australia

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

anzup.org.auROR OpenAlex
Research works
14
▲ 253% vs 2013–17
Citations
415
28.7 per fractional work
Top-10% rate
19.2%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Australian and New Zealand Urogenital and Prostate Cancer Trials Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.49× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.54× its world share, 0 worksImmunology and Micro…Chemistry: 0.21× its world share, 0 worksChemistryMathematics: 2.38× its world share, 0 worksMathematicsPhysics and Astronomy: 0.10× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.74× its world share, 0 worksHealth ProfessionsMedicine: 4.30× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 0.72× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.

Which research topics does Australian and New Zealand Urogenital and Prostate Cancer Trials Group publish most on?

By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers and Radiopharmaceutical Chemistry and Applications.

Bladder and Urothelial C…1Bladder and Urothelial Cancer Treatments: 1 fractional worksProstate Cancer Treatment and Research: 1 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksRadiopharmaceutical Chem…0Radiopharmaceutical Chemistry and Applications: 0 fractional worksTesticular diseases and treatments: 0 fractional worksUrinary Tract Infections Management: 0 fractional worksUrinary and Genital Onco…0Urinary and Genital Oncology Studies: 0 fractional worksProstate Cancer Diagnosis and Treatment: 0 fractional worksRenal cell carcinoma treatment: 0 fractional worksImmune responses and vaccinations: 0 fractional works
SurgeryPulmonary and Respiratory MedicineOncologyRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Bladder and Urothelial Cancer Treatments Surgery 1 works
  2. 2 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Testicular diseases and treatments Surgery 0 works
  6. 6 Urinary Tract Infections Management Epidemiology 0 works
  7. 7 Urinary and Genital Oncology Studies Surgery 0 works
  8. 8 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  9. 9 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  10. 10 Immune responses and vaccinations Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.8%not open50.2%

World: 28% of research is openly available.

with international co-authors31.7%domestic only68.3%

World: 19% is written across borders.

How has Australian and New Zealand Urogenital and Prostate Cancer Trials Group's research output changed?

Output in 2018–2022 was 253% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Camperdown

All research institutions in Camperdown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.